Making Sure that CAR-T Therapy for Cancer Succeeds
Academic Researchers Identify a New Process to Raise Natural Armies of Cancer-Targeting T Lymphocytes Outside the Body Unleashing More Power to the Immune System to Fight All Types of Cancers
GOOD NEWS FOR CAR-T IMMUNOTHERAPY DEVELOPERS

Researchers from Mayo Clinic and the University of Washington have developed a new culture process to improve the efficacy of engineered T cell treatments. The new method unlocks the natural fighter function of immune T-cells when they are passing through the bloodstream . . .